Superior Planning LLC’s Rapport Therapeutics RAPP Stock Holding History
Bought
Maintained
Sold
Other funds holding RAPP
SL
Superior Planning LLC's RAPP Position: Q3 2026 in Review
Superior Planning LLC opened a new position in Rapport Therapeutics (RAPP) in Q3 2026: 77 shares worth $2.59K. The stake represents ﹤0.01% of the portfolio and ranks #1472 among its holdings.
119 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.
- Superior Planning LLC held 77 shares of Rapport Therapeutics worth $2.59K as of Q3 2026.
- Rapport Therapeutics was a new Superior Planning LLC position in Q3 2026.
- Rapport Therapeutics made up ﹤0.01% of Superior Planning LLC's portfolio in Q3 2026, its #1472 holding.
- 119 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.
Based on Superior Planning LLC's 13F filing for Q3 2026, filed 12 Nov 2026.